Sarissa Capital Management LP Amarin Corp Plcuk Put Options Transaction History
Sarissa Capital Management LP
- $572 Million
- Q1 2024
Put Options
0 transactions
Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
---|
Others Institutions Holding AMRN
# of Institutions
184Shares Held
87.9MCall Options Held
528KPut Options Held
219K-
Kynam Capital Management, LP Princeton, NJ12MShares$8.3 Million1.12% of portfolio
-
Dg Capital Management, LLC New York, NY6.44MShares$4.45 Million3.54% of portfolio
-
Eversept Partners, LP New York, NY6.21MShares$4.29 Million0.42% of portfolio
-
Morgan Stanley New York, NY3.61MShares$2.49 Million0.0% of portfolio
-
Two Sigma Investments, LP New York, NY3.39MShares$2.34 Million0.01% of portfolio
About AMARIN CORP PLCUK
- Ticker AMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 403,206,016
- Market Cap $278M
- Description
- Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...